Haematology

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Blank cheque company merger creates cancer specialist Vincer...

LifeSci Acquisition – a so-called ‘blank cheque’ company – has announced a $60 million merger with Vincera Pharma that will focus on developing cancer drugs.

News

Takeda’s bleeding disorder drug Veyvondi backed for NHS use

NHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it the first and only medicine backed for what is the most common inher

Views & Analysis

Clinical decision-making insights for haematologists and onc...

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such as haematologists and oncolog

News

GSK moves further ahead in BCMA with EU okay for Blenrep

GlaxoSmithKline has approval on both sides of the Atlantic for its multiple myeloma drug Blenrep, after getting the nod from the European Commission.

News

Novartis eyes filings for leukaemia drug asciminib after pha...

A first-in-class STAMP inhibitor developed by Novartis – asciminib – has outperformed a current drug for chronic myeloid leukaemia (CML) in a head-to-head trial, setting up reg

Views & Analysis